Team

Spinning out of UC Berkeley, the Sift team brings together AI-driven discovery and deep translational immunology, with a proven track record of advancing novel immunotherapies from early concept through IND-enabling development. Collectively, the team has built and scaled high-throughput discovery platforms and led T-cell, peptide, and cell-based immunotherapy programs across leading academic labs, biotech startups, and biopharma. Merging this experience with proprietary datasets and computational pipelines, Sift is shaping a new frontier in immunotherapy, unlocking the power of pre-existing immunity to create a fundamentally new class of cancer treatments.